Lot of cash "burning" on salaries, R&D and others and no new customers at the queue. According to my broker another money will be needed what's mean more dilution of existing shareholders.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025